A tighter archive for life-science signals.
Search once, then narrow by source or topic.
FDA suspends Regenxbio gene therapy trials after patient developed brain tumor
FDA suspends Regenxbio gene therapy trials after patient developed brain tumor
HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launch
HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launch
Eikon seeks $273M IPO with pipeline led by Chinese cancer drugs
Eikon seeks $273M IPO with pipeline led by Chinese cancer drugs
Included Health launches alternative health plan
Included Health launches alternative health plan
Hengrui blazes trail as Chinese drugmakers aspire to go multinational
Hengrui blazes trail as Chinese drugmakers aspire to go multinational
Boehringer Ingelheim takes rare kidney disease drug to Phase 3 despite puzzling mid-stage data
Boehringer Ingelheim takes rare kidney disease drug to Phase 3 despite puzzling mid-stage data
CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations
CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations
Hospitals could earn more for buying US-made drugs, CMS proposes
Hospitals could earn more for buying US-made drugs, CMS proposes
Cardiff execs depart as company drops mixed Phase 2 data
Cardiff execs depart as company drops mixed Phase 2 data
UnitedHealth projects lower revenue in 2026 as it resets its business
UnitedHealth projects lower revenue in 2026 as it resets its business
FDA lifts hold on one of two Phase 3 gene editing studies by Intellia
FDA lifts hold on one of two Phase 3 gene editing studies by Intellia
Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma
Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma
AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal
AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal
Virtual women’s health company Wisp buys TBD Health
Virtual women’s health company Wisp buys TBD Health
Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere
Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere
UK-US biotech investor Epidarex raises $145M for fourth fund
UK-US biotech investor Epidarex raises $145M for fourth fund
IRA drug pricing petitions pile up at the Supreme Court
IRA drug pricing petitions pile up at the Supreme Court
Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme
Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page